EXEL | | EXELIXIS, INC. | Lamb Peter | EVP, Scientific Strategy & CSO | Dec 15, 2022 | Option Exercise | $10.04 | 40,000 | 401,600 | 430,958 | Dec 16, 2022, 08:09 PM |
EXEL | | EXELIXIS, INC. | Lamb Peter | EVP, Scientific Strategy & CSO | Nov 15, 2022 | Option Exercise | $16.71 | 7,177 | 119,928 | 410,958 | Nov 17, 2022, 08:42 PM |
EXEL | | EXELIXIS, INC. | Lamb Peter | EVP, Scientific Strategy & CSO | Aug 03, 2022 | Option Exercise | $21.49 | 7,177 | 154,234 | 418,135 | Aug 05, 2022, 09:45 PM |
EXEL | | EXELIXIS, INC. | Lamb Peter | EVP, Scientific Strategy & CSO | May 15, 2022 | Option Exercise | $20.08 | 6,123 | 122,950 | 396,362 | May 17, 2022, 08:22 PM |
EXEL | | EXELIXIS, INC. | Lamb Peter | EVP, Scientific Strategy & CSO | Feb 15, 2022 | Option Exercise | $18.59 | 20,177 | 375,090 | 360,646 | Feb 17, 2022, 08:09 PM |
EXEL | | EXELIXIS, INC. | Lamb Peter | EVP, Scientific Strategy & CSO | Dec 15, 2021 | Sale | $12.07 | 99,646 | 1,202,357 | 410,672 | Dec 17, 2021, 08:35 PM |
EXEL | | EXELIXIS, INC. | Lamb Peter | EVP, Scientific Strategy & CSO | Nov 15, 2021 | Option Exercise | $14.50 | 157,163 | 2,279,400 | 458,740 | Nov 17, 2021, 08:02 PM |
EXEL | | EXELIXIS, INC. | Lamb Peter | EVP, Scientific Strategy & CSO | Oct 15, 2021 | Option Exercise | $14.07 | 95,000 | 1,336,175 | 458,740 | Oct 15, 2021, 08:15 PM |
EXEL | | EXELIXIS, INC. | Lamb Peter | EVP, Scientific Strategy & CSO | Sep 30, 2021 | Option Exercise | $20.63 | 7,177 | 148,062 | 411,240 | Oct 04, 2021, 08:02 PM |
EXEL | | EXELIXIS, INC. | Lamb Peter | EVP, Scientific Strategy & CSO | Sep 15, 2021 | Sale | $13.33 | 95,000 | 1,266,825 | 436,967 | Sep 17, 2021, 07:56 PM |
EXEL | | EXELIXIS, INC. | Lamb Peter | EVP, Scientific Strategy & CSO | Aug 16, 2021 | Sale | $10.17 | 110,000 | 1,118,700 | 444,467 | Aug 18, 2021, 07:56 PM |
EXEL | | EXELIXIS, INC. | Lamb Peter | EVP, Scientific Strategy & CSO | Jul 15, 2021 | Sale | $9.68 | 120,000 | 1,162,200 | 449,467 | Jul 16, 2021, 07:58 PM |
EXEL | | EXELIXIS, INC. | Lamb Peter | EVP, Scientific Strategy & CSO | Jun 17, 2021 | Sale | $12.04 | 120,000 | 1,444,800 | 449,467 | Jun 22, 2021, 08:03 PM |
EXEL | | EXELIXIS, INC. | Lamb Peter | EVP, Scientific Strategy & CSO | Apr 01, 2021 | Sale | $12.33 | 120,000 | 1,479,600 | 449,467 | Apr 02, 2021, 07:51 PM |
EXEL | | EXELIXIS, INC. | Lamb Peter | EVP, Scientific Strategy & CSO | Mar 01, 2021 | Sale | $11.91 | 130,000 | 1,547,650 | 405,072 | Mar 03, 2021, 07:49 PM |
EXEL | | EXELIXIS, INC. | Lamb Peter | EVP, Scientific Strategy & CSO | Feb 15, 2021 | Option Exercise | $21.91 | 3,718 | 81,461 | 340,072 | Feb 17, 2021, 08:05 PM |
EXEL | | EXELIXIS, INC. | Lamb Peter | EVP, Scientific Strategy & CSO | Feb 03, 2021 | Option Exercise | $22.56 | 19,997 | 451,132 | 343,790 | Feb 05, 2021, 09:18 PM |
EXEL | | EXELIXIS, INC. | Lamb Peter | EVP, Scientific Strategy & CSO | Feb 01, 2021 | Option Exercise | $11.89 | 130,000 | 1,545,700 | 348,124 | Feb 03, 2021, 07:57 PM |
EXEL | | EXELIXIS, INC. | Lamb Peter | EVP, Scientific Strategy & CSO | Jan 04, 2021 | Option Exercise | $11.01 | 130,000 | 1,431,300 | 348,124 | Jan 06, 2021, 08:40 PM |
EXEL | | EXELIXIS, INC. | Lamb Peter | EVP, Scientific Strategy & CSO | Dec 18, 2020 | Option Exercise | $10.86 | 130,000 | 1,411,150 | 348,124 | Dec 22, 2020, 07:58 PM |
EXEL | | EXELIXIS, INC. | Lamb Peter | EVP, Scientific Strategy & CSO | Nov 15, 2020 | Option Exercise | $20.16 | 11,311 | 228,030 | 291,956 | Nov 17, 2020, 08:06 PM |
EXEL | | EXELIXIS, INC. | Lamb Peter | EVP, Scientific Strategy & CSO | Oct 22, 2020 | Option Exercise | $21.79 | 53,022 | 1,155,349 | 294,435 | Oct 26, 2020, 07:57 PM |
EXEL | | EXELIXIS, INC. | Lamb Peter | EVP, Scientific Strategy & CSO | Sep 02, 2020 | Option Exercise | $21.58 | 2,323 | 50,130 | 133,578 | Sep 04, 2020, 06:41 PM |
EXEL | | EXELIXIS, INC. | Lamb Peter | EVP, Scientific Strategy & CSO | Jun 08, 2020 | Sale | $14.03 | 52,000 | 729,820 | 152,531 | Jun 10, 2020, 08:19 PM |
EXEL | | EXELIXIS, INC. | Lamb Peter | EVP, Scientific Strategy & CSO | May 07, 2020 | Sale | $15.53 | 100,000 | 1,552,500 | 176,531 | May 08, 2020, 09:11 PM |
EXEL | | EXELIXIS, INC. | Lamb Peter | EVP, Scientific Strategy & CSO | Apr 06, 2020 | Option Exercise | $11.39 | 100,000 | 1,138,500 | 176,531 | Apr 08, 2020, 08:12 PM |
EXEL | | EXELIXIS, INC. | Lamb Peter | EVP, Scientific Strategy & CSO | Dec 04, 2019 | Option Exercise | $17.67 | 3,872 | 68,418 | 126,531 | Dec 06, 2019, 07:18 PM |
EXEL | | EXELIXIS, INC. | Lamb Peter | EVP, Scientific Strategy & CSO | Nov 15, 2019 | Option Exercise | $16.51 | 9,201 | 151,909 | 117,509 | Nov 15, 2019, 09:37 PM |
EXEL | | EXELIXIS, INC. | Lamb Peter | EVP, Scientific Strategy & CSO | Sep 12, 2019 | Option Exercise | $19.26 | 2,581 | 49,710 | 124,611 | Sep 13, 2019, 08:47 PM |
EXEL | | EXELIXIS, INC. | Lamb Peter | EVP, Scientific Strategy & CSO | Jun 17, 2019 | Option Exercise | $13.56 | 217,404 | 2,948,566 | 217,197 | Jun 19, 2019, 09:30 PM |
EXEL | | EXELIXIS, INC. | Lamb Peter | EVP, Scientific Strategy & CSO | Jun 18, 2019 | Option Exercise | $11.65 | 200,000 | 2,330,711 | 217,197 | Jun 19, 2019, 09:30 PM |
EXEL | | EXELIXIS, INC. | Lamb Peter | EVP, Scientific Strategy & CSO | Jun 19, 2019 | Option Exercise | $5.51 | 17,404 | 95,896 | 134,601 | Jun 19, 2019, 09:30 PM |
EXEL | | EXELIXIS, INC. | Lamb Peter | EVP, Scientific Strategy & CSO | Jun 13, 2019 | Sale | $12.80 | 55,192 | 706,182 | 144,793 | Jun 14, 2019, 08:11 PM |
EXEL | | EXELIXIS, INC. | Lamb Peter | EVP, Scientific Strategy & CSO | Nov 15, 2018 | Option Exercise | $17.45 | 9,199 | 160,523 | 119,295 | Nov 16, 2018, 08:19 PM |
EXEL | | EXELIXIS, INC. | Lamb Peter | EVP, Scientific Strategy & CSO | Nov 15, 2017 | Option Exercise | $24.75 | 2,204 | 54,549 | 126,396 | Nov 17, 2017, 07:47 PM |
EXEL | | EXELIXIS, INC. | Lamb Peter | EVP, Scientific Strategy & CSO | Mar 01, 2017 | Option Exercise | $14.78 | 90,000 | 1,329,900 | 118,600 | Mar 03, 2017, 08:18 PM |
EXEL | | EXELIXIS, INC. | Lamb Peter | EVP, Scientific Strategy & CSO | Feb 01, 2017 | Sale | $12.78 | 140,000 | 1,789,800 | 143,600 | Feb 03, 2017, 07:55 PM |
EXEL | | EXELIXIS, INC. | Lamb Peter | EVP, Scientific Strategy & CSO | Jan 03, 2017 | Sale | $10.20 | 140,000 | 1,427,436 | 143,600 | Jan 05, 2017, 08:25 PM |
EXEL | | EXELIXIS, INC. | Lamb Peter | EVP, Scientific Strategy & CSO | Dec 01, 2016 | Sale | $10.96 | 140,000 | 1,535,000 | 143,600 | Dec 02, 2016, 07:14 PM |
EXEL | | EXELIXIS, INC. | Lamb Peter | EVP, Scientific Strategy & CSO | Nov 09, 2016 | Option Exercise | $9.16 | 140,000 | 1,282,500 | 143,600 | Nov 14, 2016, 07:34 PM |
EXEL | | EXELIXIS, INC. | Lamb Peter | EVP, Scientific Strategy & CSO | Feb 11, 2016 | Option Exercise | $4.20 | 25,454 | 106,907 | 57,350 | Feb 16, 2016, 08:51 PM |
EXEL | | EXELIXIS, INC. | Lamb Peter | EVP, Discovery Research & CSO | Oct 16, 2015 | Option Exercise | $5.72 | 103,098 | 589,205 | 88,022 | Oct 19, 2015, 05:08 PM |
EXEL | | EXELIXIS, INC. | Lamb Peter | EVP, Discovery Research & CSO | Oct 12, 2015 | Option Exercise | $5.73 | 600,552 | 3,443,866 | 336,749 | Oct 14, 2015, 05:05 PM |
EXEL | | EXELIXIS, INC. | Lamb Peter | EVP, Discovery Research & CSO | Oct 13, 2015 | Option Exercise | $5.72 | 1,200 | 6,858 | 37,073 | Oct 14, 2015, 05:05 PM |